ARTICLE | Clinical News
Eylea aflibercept ophthalmic solution regulatory update
December 8, 2014 8:00 AM UTC
Japan approved Eylea aflibercept from Bayer to treat diabetic macular edema (DME). The human fusion protein that binds all forms of VEGF-A and placental growth factor ( PGF; PlGF) is approved in Ja...